Paʻakai disodium ATP CAS 987-65-5

CAS:987-65-5

Maʻemaʻe:99%

Formula Molekala:C10H17N5NaO13P3

Kaumaha Molekala:531.18

Nā EINECS:213-579-1

Ka Wā Mālama:2 mau makahiki

Nā huaʻōlelo like:ʻAdenosinetriphosphatdisodium; ʻAdenosinetriphosphat,disodium paʻakai; ʻAdenosine-5′-triphosphathydratedisodium paʻakai; ʻAdenosine-5′-triphosphatena2-paʻakai; ʻAdenosine-5′-triphosphatena2-paʻakai; ʻAdenosine-5′-triphosphatdisodiumdihydrogen paʻakai; ʻAdenosine5′-triphosphatdisodium paʻakai

Waiho i kāu leka

Nā kikoʻī huahana

Hoʻoiho

Nā Lepili Huahana

He aha ka paʻakai ATP disodium CAS 987-65-5?

ʻO ka paʻakai disodium ATP kahi metabolite o adenosine, kahi nucleoside triphosphate multifunctional i hoʻohana ʻia ma ke ʻano he coenzyme no ka hoʻoili ikehu intracellular i loko o nā cell. Hoʻoili ia i ka ikehu kemika i loko o nā cell no ka metabolism. Hoʻohana ʻia ka paʻakai disodium ATP e synthesize i nā analog deoxyadenosine diphosphate i hoʻololi ʻia e ribose ma ke ʻano he ligands receptor P2Y1.

Nā kikoʻī

helehelena	Pauka keʻokeʻo a i ʻole ka pauka keʻokeʻo ʻole a i ʻole ka pauka kristal, hygroscopic.
Ka nui o ka ʻāpana	>95% e hele ma waena o 80 mesh.
pH	2.5～3.5
Ka hiki ke hoʻoheheʻe ʻia	Hoʻoheheʻe ʻia i ka wai; hoʻoheheʻe ʻole ʻia i ka ethanol a me ka ether.
ʻOder	ʻAʻohe ʻala
Ka nui o ka wai	6.0%~12.0%
Kolorida	≤0.05%
Paʻakai hao	≤0.001%
Nā metala kaumaha	≤0.001%
Ke alakaʻi	≤2.0ppm
ʻArsenika	≤1.0ppm

Noi

1. Nā hoʻohana noiʻi ʻoihana a me ka ʻepekema
(1) Nā mea maka hoʻonaninani: hoʻohui ʻia i nā huahana mālama ʻili anti-kahiko, hiki iā ia ke hoʻomaikaʻi i ka elasticity o ka ʻili a me ka ʻālohilohi ma o ka hoʻoulu ʻana i ka metabolism ikehu cell.
(2) Nā mea hoʻohui meaʻai: hoʻohana ʻia ma ke ʻano he mea hoʻonui meaʻai i nā mea inu haʻuki a me nā meaʻai hana e hoʻopiha koke i ka ikehu.
2. Nā wahi lapaʻau lapaʻau
(1) Nā maʻi ʻōnaehana cardiovascular: hoʻohana ʻia no ka hāʻule ʻana o ka puʻuwai, myocarditis, myocardial infarction a me ka cerebral arteriosclerosis, a me nā mea ʻē aʻe, ma ka hoʻomaikaʻi ʻana i ka metabolism ikehu myocardial a me ka hoʻonui ʻana i nā aʻa coronary (hoʻonui i ke kahe koko ma kahi o 30%), e hōʻoluʻolu ana i nā hōʻailona ischemia myocardial. No ka laʻana, i nā poʻe maʻi me ka myocardial infarction acute, hiki i ka ATP disodium ke hoʻopōkole i ka manawa hāʻule o ka ʻāpana ST a hōʻemi i ka waiwai kiʻekiʻe o ka myocardial enzyme spectrum.
(2) Nā maʻi ʻōnaehana aʻalolo: mālama kōkua i nā hopena o ke kahe koko o ka lolo, ka hōʻino ʻana o ka lolo a me ka atrophy muscular holomua, ma ke komo ʻana i ka pale koko-lolo (ʻo ka permeability ma kahi o 65%), e paipai ana i ka hoʻoponopono ʻana o ka membrane cell nerve a me ka hana hou ʻana o ke kaʻina hana aʻalolo, a me ka hoʻomaikaʻi ʻana i ka wikiwiki o ke alakaʻi ʻana o ke aʻalolo.
(3) Nā maʻi metabolic: I ka mālama ʻana i ka hepatitis a me ka cirrhosis, hiki i ka ATP disodium ke hoʻonui i ka hana mitochondrial o nā hepatocytes, e hoʻolalelale i ka hoʻoponopono hepatocyte, a hoʻemi i nā pae ALT a me AST; loaʻa iā ia kahi hopena hoʻomaikaʻi kōkua i nā pilikia maʻi diabetes (e like me ka neuropathy peripheral).
3. Nā wahi noi e kū mai ana
(1) ʻŌnaehana lawe lāʻau i kuhikuhi ʻia: Hiki ke hoʻohana ʻia ka ATP disodium ma ke ʻano he mea hoʻololi lawe, i hui pū ʻia me nā liposomes a i ʻole nā nanoparticles, e hoʻokō i ka lawe lāʻau i kuhikuhi ʻia ma o ka endocytosis receptor-mediated. No ka laʻana, i ka mālama ʻana i ka maʻi puʻupuʻu, hiki i nā nanomedicines i hoʻololi ʻia e ATP ke hoʻomaikaʻi i ka pono pepehi koho o nā lāʻau chemotherapy ma nā cell cancer.
(2) Moʻomeheu kelepona a me nā biopharmaceuticals: Ma ke ʻano he ʻāpana koʻikoʻi o ka medium moʻomeheu kelepona, hiki i ka ATP disodium ke hoʻolaha i ka ulu ʻana a me ka hōʻike ʻana o ka protein o nā kelepona CHO, nā kelepona HEK293, a pēlā aku, a hoʻohana nui ʻia i ka hana ʻana o ka antibody monoclonal.